Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
24 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to NeoGenomics, Inc.’s names, not what it holds today.
Patents granted
24
24 utility, 1976 to Dec 31, 2025
Granted in 2025
6
Against 2 in 2024 and 3 in 2023
Applications published
45
9 of them in 2025
Names they are printed under
4
a subsidiary
By yearGrantedApplications published
'14'16'17'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Biotechnology12
Computer technology3
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
Inivata Ltd. a subsidiary
named as the applicant on its applications, in GB. 1 more under the same name are not counted (printed in US)
0 granted
33 publishedInivata Ltd. a subsidiary
GB, as the owner printed on each patent
18 granted
2 publishedNeoGenomics Laboratories, Inc. a subsidiary
US, as the owner printed on each patent. 1 more under the same name are not counted (printed in GB)
6 granted
3 publishedNEOGENOMICS LABORATORIES, INC. a subsidiary
named as the applicant on its applications, in US
0 granted
7 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Dec 30, 2025 | 12,509,733 | Methods and systems for detecting a primary disease | Biotechnology | Inivata Ltd. |
| Aug 5, 2025 | 12,378,595 | Method for the analysis of minimal residual disease | Computer technology | Inivata Ltd. |
| Jul 29, 2025 | 12,371,744 | Method of sequencing a nucleic acid of interest | Biotechnology | Inivata Ltd. |
| Jul 22, 2025 | 12,365,940 | Methods of labelling nucleic acids using variable length oligonucleotides | Biotechnology | Inivata Ltd. |
| Mar 11, 2025 | 12,247,249 | Method for amplifying a genomic sample | Biotechnology | Inivata Ltd. |
| Jan 14, 2025 | 12,195,807 | Method of treating a cancer patient without the need for a tissue biopsy | Biotechnology | Inivata Ltd. |
| Dec 10, 2024 | 12,163,187 | Methods of sequencing nucleic acids and error correction of sequence reads | Biotechnology | Inivata Ltd. |
| Sep 10, 2024 | 12,084,724 | Computational method for detecting fusion events | Biotechnology | Inivata Ltd. |
| Oct 17, 2023 | 11,788,116 | Method for the analysis of minimal residual disease | Computer technology | Inivata Ltd. |
| Jun 13, 2023 | 11,674,175 | Methods of labelling nucleic acids | Biotechnology | Inivata Ltd. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Dec 11, 2025 | 2025/0378907 | CANCER-ASSOCIATED GENETIC VARIANT FILTERING USING MUTATIONAL SIGNATURES | Computer technology | Inivata Ltd. |
| Nov 6, 2025 | 2025/0340926 | VARIABLE REPLICATE MULTIPLEX PCR | Computer technology | Inivata Ltd. |
| Aug 28, 2025 | 2025/0273296 | METHOD OF DETECTING CANCER DNA IN A SAMPLE | Computer technology | Inivata Ltd. |
| Aug 28, 2025 | 2025/0270629 | METHOD FOR AMPLIFYING A GENOMIC SAMPLE | Biotechnology | Inivata Ltd. |
| Jun 12, 2025 | 2025/0188547 | METHOD OF TREATING A CANCER PATIENT WITHOUT THE NEED FOR A TISSUE BIOPSY | Biotechnology | Inivata Ltd. |
| May 8, 2025 | 2025/0146064 | METHODS OF SEQUENCING NUCLEIC ACIDS AND ERROR CORRECTION OF SEQUENCE READS | Biotechnology | Inivata Ltd. |
| Feb 27, 2025 | 2025/0066847 | METHODS OF LABELLING NUCLEIC ACIDS | Biotechnology | Inivata Ltd. · patent 12,371,744 granted from it |
| Feb 13, 2025 | 2025/0051841 | METHODS OF LABELLING NUCLEIC ACIDS | Biotechnology | Inivata Ltd. |
| Jan 30, 2025 | 2025/0037792 | COMPUTATIONAL ASSESSMENT OF GENETIC VARIANT QUALITY | Computer technology | Inivata Ltd. |
| Dec 26, 2024 | 2024/0425930 | METHODS FOR SELECTIVE SEQUENCING OF CANCER DNA | Biotechnology | Inivata Ltd. |
What it applied for, 2024 to 2025: Biotechnology 7 · Computer technology 5 · Analysis of biological materials 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.